K, F., WP, H., N, B., H, P., P, V., A, E., . . . UK, B. (2025). Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974. Vaccines, 13(8), . https://doi.org/10.3390/vaccines13080831
Chicago Style (17th ed.) CitationK, Feemster, Hausdorff WP, Banniettis N, Platt H, Velentgas P, Esteves-Jaramillo A, Burton RL, Nahm MH, and Buchwald UK. "Correction: Feemster Et Al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974." Vaccines 13, no. 8 (2025). https://doi.org/10.3390/vaccines13080831.
MLA (9th ed.) CitationK, Feemster, et al. "Correction: Feemster Et Al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974." Vaccines, vol. 13, no. 8, 2025, https://doi.org/10.3390/vaccines13080831.